GBX2
Basic information
Region (hg38): 2:236165236-236168386
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GBX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 0 | 2 |
Variants in GBX2
This is a list of pathogenic ClinVar variants found in the GBX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-236166032-G-T | not specified | Uncertain significance (Nov 01, 2021) | ||
2-236166184-C-T | Benign (Jul 23, 2018) | |||
2-236166192-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
2-236166232-A-G | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
2-236166252-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
2-236166255-C-A | not specified | Uncertain significance (Mar 19, 2024) | ||
2-236166260-C-G | not specified | Uncertain significance (Oct 05, 2023) | ||
2-236166276-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
2-236166290-G-T | not specified | Uncertain significance (Nov 09, 2024) | ||
2-236166337-G-C | not specified | Uncertain significance (Sep 26, 2024) | ||
2-236167460-T-C | not specified | Uncertain significance (Jul 10, 2024) | ||
2-236167514-C-G | not specified | Uncertain significance (Oct 24, 2024) | ||
2-236167550-G-A | not specified | Uncertain significance (Apr 20, 2023) | ||
2-236167565-C-T | not specified | Uncertain significance (May 08, 2024) | ||
2-236167566-C-G | not specified | Uncertain significance (Jun 18, 2021) | ||
2-236167568-C-A | not specified | Uncertain significance (Jun 10, 2022) | ||
2-236167599-G-C | not specified | Uncertain significance (Jul 27, 2024) | ||
2-236167612-C-G | Benign (Jul 23, 2018) | |||
2-236167643-C-A | not specified | Uncertain significance (Jan 10, 2023) | ||
2-236167657-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
2-236167678-C-T | not specified | Uncertain significance (May 17, 2023) | ||
2-236167682-C-G | not specified | Uncertain significance (May 27, 2022) | ||
2-236167724-A-G | not specified | Uncertain significance (Jun 17, 2022) | ||
2-236167754-G-T | not specified | Uncertain significance (Dec 14, 2023) | ||
2-236167808-A-G | not specified | Uncertain significance (Nov 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GBX2 | protein_coding | protein_coding | ENST00000306318 | 2 | 3134 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.713 | 0.284 | 125660 | 0 | 3 | 125663 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.40 | 134 | 188 | 0.712 | 0.00000961 | 2221 |
Missense in Polyphen | 46 | 75.857 | 0.6064 | 865 | ||
Synonymous | 1.62 | 67 | 86.1 | 0.778 | 0.00000448 | 731 |
Loss of Function | 2.37 | 1 | 8.43 | 0.119 | 3.73e-7 | 98 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000993 | 0.0000993 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000179 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May act as a transcription factor for cell pluripotency and differentiation in the embryo.;
- Pathway
- Neural Crest Differentiation;Dopaminergic Neurogenesis
(Consensus)
Recessive Scores
- pRec
- 0.238
Intolerance Scores
- loftool
- 0.0466
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 36.86
Haploinsufficiency Scores
- pHI
- 0.799
- hipred
- Y
- hipred_score
- 0.670
- ghis
- 0.436
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.576
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gbx2
- Phenotype
- craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; taste/olfaction phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; embryo phenotype;
Zebrafish Information Network
- Gene name
- gbx2
- Affected structure
- rhombomere 4
- Phenotype tag
- abnormal
- Phenotype quality
- apoptotic
Gene ontology
- Biological process
- branching involved in blood vessel morphogenesis;neural crest cell migration;nervous system development;axon guidance;cerebellum development;midbrain-hindbrain boundary morphogenesis;rhombomere 2 development;thalamus development;forebrain neuron development;cerebellar granule cell precursor proliferation;hindbrain development;inner ear morphogenesis;positive regulation of transcription by RNA polymerase II;autonomic nervous system development;regulation of nervous system development
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity